PMID: 6407136Feb 1, 1983Paper

Surgical treatment of emphysematous bullae: late outcome

Thorax
M G Pearson, C Ogilvie

Abstract

From 1967 to 1972 12 patients were operated on for emphysematous bullae in the Liverpool regional cardiothoracic centre. The patient with the poorest lung function died in the immediate postoperative period but the remainder survived for more than five years. All but one of the survivors showed evidence of benefit three to six months after surgery and all those not retired returned to full-time employment for at least five years. Nine patients were reviewed 5-10 years after surgery. These all reported a gradual return of dyspnoea, which was matched by a falling one-second forced expiratory volume (FEV1) (mean fall 82 ml a year); but five were still maintaining some of their postoperative improvement. When mean preoperative lung function values were compared with the values obtained 5-10 years later there was still a significant improvement in forced vital capacity; but FEV1, residual volume, transfer coefficient, and arterial oxygen and carbon dioxide tensions were unchanged. Chest radiographs showed no new bullae or (except in one case) any increase in size of pre-existing bullae. We conclude that the removal of large emphysematous bullae did not hasten the progress of the underlying emphysema and that in most patients some be...Continue Reading

References

Oct 1, 1978·Anesthesiology·C J Coté
Feb 20, 1969·The New England Journal of Medicine·B Burrows, R H Earle
Dec 1, 1981·Thorax·P D PotgieterA D Ferguson

❮ Previous
Next ❯

Citations

Jan 1, 1984·Clinical Radiology·D H Carr, N B Pride
Aug 26, 2009·Journal of Thoracic Imaging·Victor Kim, Robert M Steiner
Jan 27, 1990·BMJ : British Medical Journal·W J Kinnear, A E Tattersfield
Jul 1, 1989·Thorax·M D MorganH R Matthews
Jan 1, 2011·Case Reports in Pulmonology·Nidhi Sood, Nikhil Sood
Dec 25, 2013·The Annals of Thoracic Surgery·Pradheep KrishnamohanClaude Deschamps
Jan 1, 1992·Chest·G D Nickoladze
Oct 1, 1991·Chest·J F WadeC G Irvin
Aug 19, 1999·The American Journal of the Medical Sciences·D K PayneM W Owens
Oct 20, 2010·The Surgical Clinics of North America·Victor van BerkelBryan F Meyers
Jan 20, 2009·La Presse médicale·Hervé Mal
Nov 21, 2007·The Journal of Thoracic and Cardiovascular Surgery·Tommaso Claudio MineoDavide Mineo
Aug 28, 2007·Clinics in Chest Medicine·David J Lederer, Selim M Arcasoy
Sep 1, 2004·The Annals of Thoracic Surgery·Paul H SchipperJoel D Cooper
Sep 1, 1991·The Annals of Thoracic Surgery·R R KlingmanT R DeMeester
Sep 13, 2012·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·S I GunnarssonT Gudbjartsson
Aug 4, 1999·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·T De GiacomoG F Coloni
Mar 1, 1986·The Australian and New Zealand Journal of Surgery·C J O'BrienP Gianoutsos
Jul 31, 2020·Journal of Cardiothoracic Surgery·Dmitry Borisovich GillerMikhail Yegorovich Sinelnikov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.